Our study revealed the critical role of IGF2-mediated autophagy in the activation of CAFs, more importantly, the interplay between lung cancer cells and stromal fibroblasts in the TME, and identified IGF2 as a candidate target for lung cancer treatment. This evidence concerns the gene IGF2 and lung carcinoma.